Research shows that heart attacks are becoming more prevalent among adults younger than 50—and the outcomes are worse for women. The good news is we know how to prevent them. Heart attacks, or ...
Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback